Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Eversept Partners, LP
Form 13F · Q2 2026

Eversept Partners, LP

CIK 1697013Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.9B
Reported book value
120
Positions
12
Quarters on record
Top 50
Positions

Eversept Partners, LP — holdings

Top 50 positions of 120, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1UTHR United Therapeutics Corp Del287,668+8.9%$156M8.1%
2ABIVAX SA Abivax Sa913,880−2.2%$122M6.3%
3EHC Encompass Health Corp1.0M+429.1%$104M5.4%
4ENSG Ensign Group Inc602,079+3978.8%$97M5.0%
5VERA Vera Therapeutics Inc2.2M+1.8%$95M4.9%
6CLDX Celldex Therapeutics Inc New1.8M−0.1%$66M3.4%
7SNDX Syndax Pharmaceuticals Inc2.8M−3.0%$61M3.2%
8BROOKDALE SR LIVING INC Brookdale Sr Living Inc3.4M−4.8%$55M2.8%
9IONS Ionis Pharmaceuticals Inc664,684+5.2%$53M2.7%
10NTRA Natera Inc175,807−54.3%$48M2.5%
11TVTX Travere Therapeutics Inc798,973+47.2%$45M2.4%
12CTRE Caretrust Reit Inc1.1M—$43M2.2%
13HCA Hca Healthcare Inc98,252+24.0%$38M2.0%
14PCVX Vaxcyte Inc629,952−31.8%$37M1.9%
15LQDA Liquidia Corporation428,652−36.7%$34M1.8%
16CYH Community Health Sys Inc New7.9M−9.4%$26M1.4%
17GSK Gsk Plc481,833−73.0%$25M1.3%
18CHE Chemed Corp New52,523+69.1%$24M1.3%
19LLY Eli Lilly & Co20,116+5.9%$24M1.3%
20GERN Geron Corp18.7M−0.6%$24M1.2%
21VKTX Viking Therapeutics Inc602,922+152.2%$24M1.2%
22OMEGA HEALTHCARE INVS INC Omega Healthcare Invs Inc483,547−17.4%$23M1.2%
23PODD Insulet Corp148,816+3.7%$23M1.2%
24THC Tenet Healthcare Corp114,199+287.0%$21M1.1%
25UNH Unitedhealth Group Inc51,145—$21M1.1%
26WELL Welltower Inc87,312−51.7%$20M1.0%
27BBNX Beta Bionics Inc1.2M−11.7%$20M1.0%
28COGT Cogent Biosciences Inc490,235—$19M1.0%
29BCRX Biocryst Pharmaceuticals Inc1.9M−38.6%$19M1.0%
30MOH Molina Healthcare Inc80,594+145.6%$18M1.0%
31PNTG Pennant Group Inc460,272+47.4%$17M0.9%
32LTC PPTYS INC Ltc Pptys Inc420,640+31.0%$16M0.8%
33INSM Insmed Inc149,209—$16M0.8%
34VRDN Viridian Therapeutics Inc831,142+16.5%$15M0.8%
35BMRN Biomarin Pharmaceutical Inc249,607+20.1%$14M0.7%
36AMN HEALTHCARE SVCS INC Amn Healthcare Svcs Inc428,531—$14M0.7%
37CELC Celcuity Inc127,931—$13M0.7%
38PHVS Pharvaris N V386,383−5.1%$13M0.7%
39CTMX Cytomx Therapeutics Inc.3.6M+11.6%$13M0.7%
40HUM Humana Inc31,171—$12M0.6%
41XENE Xenon Pharmaceuticals Inc196,532+51.7%$12M0.6%
42CRVS Corvus Pharmaceuticals Inc747,994—$11M0.6%
43ASND Ascendis Pharma A/S41,621—$11M0.6%
44BRKR Bruker Corp182,894+56.3%$11M0.6%
45MRNA Moderna Inc152,122−4.7%$11M0.6%
46GPCR Structure Therapeutics Inc196,302+42.2%$11M0.5%
47DFTX Definium Therapeutics Inc217,185+35.1%$10M0.5%
48CMPS Compass Pathways Plc672,825−0.8%$10M0.5%
49NAMS Newamsterdam Pharma Company275,471−3.6%$9M0.5%
50RVTY Revvity Inc83,624−1.4%$9M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.